Prevention of late lumen loss after coronary angioplasty by photodynamic therapy: Role of activated neutrophils

被引:24
|
作者
Sluiter, W
deVree, WJA
Pietersma, A
Koster, JF
机构
[1] Department of Biochemistry, Faculty of Medicine and Health Sciences, Erasmus University, Rotterdam
[2] Department of Biochemistry, Cardiovascular Research Institute, Erasmus University, 3000 DR Rotterdam
关键词
coronary angioplasty; intimal hyperplasia; restenosis; smooth muscle cell; neutrophil; photodynamic therapy;
D O I
10.1007/BF00227904
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Restenosis after coronary angioplasty arises from fibrocellular intimal hyperplasia and possibly failure of the artery to enlarge adequately. Which mechanisms underlie this process is only partly understood. No drugs have been clinically effective in reducing the incidence of restenosis. Since recently, photodynamic therapy (PDT) is being investigated as a possible treatment for intimal hyperplasia. PDT involves the systemic administration of a light-excitable photosensitizer that is taken up rather preferentially by rapidly proliferating cells. During laser irradiation light energy is transferred from the photosensitizer to oxygen generating the highly reactive singlet oxygen. This potent oxidizer can cause severe cellular damage. After PDT of a balloon-injured artery from the rat and rabbit the media remained acellular for several weeks to months, and intimal hyperplasia did not occur. The endothelial lining regenerated by two weeks, but why smooth muscle cells did not repopulated the media is not known. Neutrophils seem to play an important role in the prevention of restenosis after coronary angioplasty, since the activation status of this type of phagocyte is directly related to vessel diameter at late follow-up. Furthermore, it has been observed that neutrophils adhere to the microvascular wall upon PDT in vivo. In vitro findings suggest that the increased neutrophil adherence was not dependent on a decreased release of the anti-adhesive factors NO and prostacyclin by the PDT-treated endothelial cells. Furthermore, PDT did not stimulate the expression of P-selectin by the endothelial cells, one of the adhesion receptors for neutrophils. The endothelial cells only retract upon PDT allowing the adherence of neutrophils by their beta(2)-integrin adhesion receptors to the subendothelial matrix. On the basis of these findings, we presume that the successful prevention of intimal hyperplasia by PDT partly depends on the presence of the neutrophil at the site of the lesion.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 50 条
  • [21] PROBUCOL THERAPY IN THE PREVENTION OF RESTENOSIS AFTER SUCCESSFUL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    SETSUDA, M
    INDEN, M
    HIRAOKA, N
    OKAMOTO, S
    TANAKA, H
    OKINAKA, T
    NISHIMURA, Y
    OKANO, H
    KOUJI, T
    KONISHI, T
    NAKANO, T
    CLINICAL THERAPEUTICS, 1993, 15 (02) : 374 - 382
  • [22] A QUANTITATIVE-EVALUATION OF LATE CHANGES IN CORONARY LUMEN AREA FOLLOWING ANGIOPLASTY
    JOHNSON, MR
    BRAYDEN, GP
    ERICKSEN, EE
    RIPLEY, JE
    WHITE, CW
    CIRCULATION, 1985, 72 (04) : 456 - 456
  • [23] Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions
    Yamamoto, Masaya
    Hara, Hisao
    Kubota, Shuji
    Hiroi, Yukio
    EUROINTERVENTION, 2024, 20 (09) : 602 - 612
  • [24] Late lumen enlargement after drug-coated balloon angioplasty for de novo coronary artery disease
    Onishi, Takayuki
    Onishi, Yuko
    Kobayashi, Isshi
    Sato, Yasuhiro
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2021, 36 (03) : 311 - 318
  • [25] Late lumen enlargement after drug-coated balloon angioplasty for de novo coronary artery disease
    Takayuki Onishi
    Yuko Onishi
    Isshi Kobayashi
    Yasuhiro Sato
    Cardiovascular Intervention and Therapeutics, 2021, 36 : 311 - 318
  • [26] Greater late lumen loss after successful coronary balloon angioplasty in the proximal left anterior descending coronary artery is not explained by extent of vessel wall damage or plaque burden
    Kok, WEM
    Peters, RJG
    Pasterkamp, G
    Di Mario, C
    Serruys, PW
    Prins, M
    Visser, CA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 382 - 388
  • [27] CARVEDILOL IN THE PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY
    DESMET, WJ
    DESCHEERDER, IK
    EMANUELSSON, H
    HJALMARSSON, A
    PIESSENS, JH
    CIRCULATION, 1995, 92 (08) : 1641 - 1641
  • [28] Mechanisms and prevention of restenosis after coronary angioplasty
    Drechsel, S
    Bertel, O
    Lafont, A
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 128 (13) : 497 - 507
  • [29] CORONARY ANGIOPLASTY AFTER THROMBOLYTIC THERAPY
    LABLANCHE, JM
    DANCHIN, N
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1992, 85 (05): : 729 - 735
  • [30] A DISTINCTION BETWEEN PROCESS AND OUTCOME OF LUMEN RENARROWING AFTER CORONARY ANGIOPLASTY
    COHEN, EA
    LESPERANCE, J
    SYKORA, K
    BOURASSA, MG
    SCHWARTZ, L
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (13): : 962 - 964